Welcome to our dedicated page for Astronics SEC filings (Ticker: ATRO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Astronics Corporation (NASDAQ: ATRO) SEC filings page on Stock Titan brings together the company’s regulatory disclosures from the U.S. Securities and Exchange Commission, along with AI-powered tools to help interpret them. As a supplier of advanced technologies and products to aerospace, defense and other mission-critical industries, Astronics uses its filings to report on segment performance, capital structure, risk factors and material agreements.
Investors can review current reports on Form 8-K that describe material events such as the entry into a new cash flow-based revolving credit facility, the termination of a prior asset-based credit agreement, and the issuance of 0% Convertible Senior Notes due 2031 paired with capped call transactions. These filings outline key terms, covenants, leverage and interest coverage ratios, and the use of proceeds for refinancing existing convertible notes and supporting general corporate purposes.
In addition to 8-Ks, Astronics’ annual reports on Form 10-K and quarterly reports on Form 10-Q (accessible via EDGAR) provide detail on the Aerospace and Test Systems segments, including how the company categorizes its markets, discloses research and development expense, and discusses bookings and backlog. Proxy materials and other filings offer further insight into governance and capital structure.
Stock Titan enhances access to these documents with AI-powered summaries that explain complex sections, highlight important terms in credit agreements and indentures, and clarify the implications of convertible note offerings and covenant packages. Users can also track insider transaction reports on Form 4 and other ownership-related filings to see how executives and significant holders are trading Astronics stock. Together, these tools help readers navigate Astronics’ regulatory record without manually parsing every page of each filing.
MORAN MARK J reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corporation director Mark J. Moran received a stock bonus award of 1,533 shares of $.01 par value common stock as compensation for his board service. The award was granted at no cash cost and increases his directly owned stake to 44,056 shares.
Mulato James reported acquisition or exercise transactions in this Form 4 filing.
Astronics Corp reported that James Mulato, President of Astronics Test Systems, received a grant of 7,675 restricted stock units on February 19, 2026 at no cash cost. Each unit represents the right to receive one share of common stock at settlement.
The filing explains that vesting of these restricted stock units depends on Astronics Corp's average annual adjusted EBITDA over specified multi‑year periods. Between 50% and 150% of the applicable target unit amounts may vest on future February dates, with the actual vesting percentage determined by the company’s performance.
Capital International Investors has filed a Schedule 13G reporting a passive ownership stake in Astronics Corp. common stock. The firm is deemed to beneficially own 1,849,886 shares, representing 5.9% of Astronics’ 31,619,410 shares believed to be outstanding as of the reported date.
The filing states Capital International Investors has sole voting and dispositive power over all 1,849,886 shares and no shared power. It also certifies the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Astronics.
American Century Investment Management and related entities reported a significant ownership position in Astronics Corporation. They disclosed beneficial ownership of 1,764,235 shares of Astronics common stock, representing 5.6% of the outstanding class as of December 31, 2025.
American Century and its parent American Century Companies, Inc., together with the Stowers Institute for Medical Research, reported sole voting power over 1,453,455 shares and sole dispositive power over 1,764,235 shares, with no shared voting or dispositive power. They certified that the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics.
PEABODY MARK reported disposition transactions in a Form 4 filing for ATRO. The filing lists transactions totaling 2,500 shares. Following the reported transactions, holdings were 183,445 shares.
State Street Corporation has disclosed a significant ownership position in Astronics Corp common stock. It reports beneficial ownership of 1,832,179 shares, representing 5.8% of Astronics’ common stock as of 12/31/2025.
State Street has shared voting power over 1,755,956 shares and shared dispositive power over 1,832,179 shares, with no sole voting or dispositive power. The firm states the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics.
Astronics Corporation filed a current report to note that on February 5, 2026 it issued a news release announcing preliminary unaudited adjusted EBITDA margins for the fourth quarter and full year of 2025. The company also highlighted plans to webcast its presentations at the TD Cowen Aerospace & Defense Conference.
BlackRock, Inc. has filed an amended Schedule 13G showing a significant passive stake in Astronics Corp common stock. As of 12/31/2025, BlackRock reports beneficial ownership of 2,749,452 shares, representing 8.7% of the outstanding common stock. BlackRock has sole voting power over 2,701,240 shares and sole dispositive power over all 2,749,452 shares, with no shared voting or dispositive power.
The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Astronics. Various underlying clients have rights to dividends or sale proceeds, but no single client has more than five percent of Astronics’ outstanding common shares.
Astronics Corp’s major shareholder group 325 Capital and related reporting persons have amended their Schedule 13D to disclose that they no longer beneficially own any Astronics common stock. The amendment states that as of October 15, 2025, these reporting persons ceased to beneficially own more than 5% of Astronics’ outstanding shares. As of the latest referenced date, October 30, 2025, the company had 31,619,410 common shares outstanding. Each reporting person now reports beneficial ownership of 0 shares, representing 0% of the class, with no voting or dispositive power over Astronics stock.
Astronics Corporation filed a current report describing information shared at recent investor conferences. On January 13 and 14, 2026, the company presented preliminary revenue, bookings and backlog for the fourth quarter and full year 2025, along with its previously announced outlook for 2026. The presentation was also updated to add revenue expectations for Astronics’ Test segment within the 2026 outlook.
This updated investor presentation is attached as Exhibit 99.1 and is available on the company’s investor relations website. The company specifies that the information in this report and the exhibit is being furnished, not filed, which limits how it is treated under securities law.